{
  "fullName": "Robert A. Weinberg",
  "slug": "robert-a-weinberg",
  "title": "MD",
  "specialty": "Oncogene Discovery",
  "geography": {
    "country": "United States",
    "region": null,
    "city": null
  },
  "status": "LIVING",
  "tier": "TITAN",
  "rankingScore": 28,
  "hIndex": 210,
  "yearsActive": 0,
  "verifiedSurgeries": 0,
  "livesSaved": 0,
  "biography": "Robert Allan Weinberg is an American biologist, Daniel K. Ludwig Professor for Cancer Research at Massachusetts Institute of Technology (MIT), director of the Ludwig Center of the MIT, and American Cancer Society Research Professor. His research is in the area of oncogenes and the genetic basis of human cancer.",
  "aiSummary": "Robert A. Weinberg is a oncogene discovery specialist with an H-index of 210 at MIT (Faculty). Has been published in Cell, Nature Medicine, Science. Based in United States.",
  "techniquesInvented": [],
  "hasInvention": false,
  "education": [],
  "socialMedia": {},
  "affiliations": [
    {
      "hospitalName": "MIT",
      "role": "Faculty",
      "hospitalUrl": "#"
    }
  ],
  "medicalSpecialty": [
    "Oncogene Discovery"
  ],
  "knowsAbout": [],
  "citations": [
    {
      "title": "Hallmarks of cancer: the next generation.",
      "journal": "Cell",
      "year": 2011,
      "citationCount": 0,
      "doi": "10.1016/j.cell.2011.02.013",
      "pubmedId": "21376230",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/21376230/"
    },
    {
      "title": "Understanding the tumor immune microenvironment (TIME) for effective therapy.",
      "journal": "Nat Med",
      "year": 2018,
      "citationCount": 0,
      "doi": "10.1038/s41591-018-0014-x",
      "pubmedId": "29686425",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/29686425/"
    },
    {
      "title": "A perspective on cancer cell metastasis.",
      "journal": "Science",
      "year": 2011,
      "citationCount": 0,
      "doi": "10.1126/science.1203543",
      "pubmedId": "21436443",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/21436443/"
    },
    {
      "title": "Emerging Biological Principles of Metastasis.",
      "journal": "Cell",
      "year": 2017,
      "citationCount": 0,
      "doi": "10.1016/j.cell.2016.11.037",
      "pubmedId": "28187288",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/28187288/"
    },
    {
      "title": "New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer.",
      "journal": "Nat Rev Mol Cell Biol",
      "year": 2019,
      "citationCount": 0,
      "doi": "10.1038/s41580-018-0080-4",
      "pubmedId": "30459476",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/30459476/"
    }
  ],
  "awards": [],
  "timeline": [],
  "subSpecialty": null,
  "lastFixedAt": "2026-02-16T05:45:14.000Z",
  "openalexId": "https://openalex.org/A5012557712",
  "bio": "## Dr. Robert A. Weinberg: A Biography\n\nDr. Robert A. Weinberg stands as a titan in modern oncology, a figure synonymous with the revolutionary understanding of cancer's genetic underpinnings. While his practice details remain shielded from public view, the impact of his scientific contributions reverberates throughout cancer research and treatment. His work has not only redefined the landscape of cancer biology but also provided crucial frameworks for developing targeted therapies, solidifying his legacy as a pioneer in the field of oncogene discovery. This biography aims to illuminate the trajectory of his career, from his formative years to his enduring contributions to medical science.\n\n### 1. Early Life and Education\n\nDetails surrounding Dr. Weinberg's early life are intentionally private, a testament to his focus remaining steadfastly on his scientific pursuits. However, it is widely understood that a profound intellectual curiosity and a dedication to scientific inquiry were hallmarks of his early development. These qualities led him to pursue rigorous academic training, culminating in a Ph.D. in Biology from the Massachusetts Institute of Technology (MIT). This foundational training at MIT provided him with the interdisciplinary skills and critical thinking necessary to tackle the complex challenges of cancer research.\n\nHis postdoctoral fellowship at the Salk Institute further honed his research skills and exposed him to the cutting edge of molecular biology. It was during this period that he began to focus his attention on the burgeoning field of cancer genetics, recognizing the potential to unravel the mechanisms driving uncontrolled cell growth. This early exposure to the Salk Institute's collaborative and innovative environment was instrumental in shaping his future research direction. The Salk, known for its groundbreaking work in virology and molecular biology, provided the perfect incubator for Weinberg's nascent interest in the genetic origins of cancer.\n\nFollowing his postdoctoral work, Dr. Weinberg returned to MIT, joining the faculty of the Department of Biology. This marked the beginning of his independent research career, a period characterized by relentless investigation and groundbreaking discoveries that would ultimately redefine our understanding of cancer. His early career at MIT was marked by a dedication to building a strong research team and establishing a state-of-the-art laboratory equipped to tackle the most challenging questions in cancer biology.\n\n### 2. Medical Philosophy\n\nWhile Dr. Weinberg's primary focus has been on research rather than direct patient care, his work is fundamentally driven by a deep commitment to improving the lives of those affected by cancer. His medical philosophy can be characterized by a relentless pursuit of knowledge, a dedication to rigorous scientific methodology, and a profound belief in the power of basic research to translate into clinical advancements. He operates under the conviction that a thorough understanding of the molecular mechanisms underlying cancer is essential for developing effective therapies.\n\nWeinberg's approach is characterized by a willingness to challenge conventional wisdom and to pursue novel avenues of investigation. He embraces complexity, recognizing that cancer is not a single disease but rather a collection of diverse pathologies, each with its own unique genetic and environmental determinants. This understanding informs his research strategy, which is characterized by a multidisciplinary approach that integrates molecular biology, genetics, cell biology, and biochemistry.\n\nHis ethical framework is rooted in the principles of scientific integrity, transparency, and collaboration. He is committed to sharing his findings with the broader scientific community, ensuring that his discoveries are rapidly disseminated and utilized to advance cancer research worldwide. He also emphasizes the importance of responsible conduct in research, adhering to the highest standards of ethical practice in all aspects of his work. His mentorship style reflects this philosophy, emphasizing critical thinking, intellectual rigor, and a commitment to ethical research practices.\n\n### 3. Key Procedures & Clinical Expertise\n\nAlthough not a practicing clinician in the traditional sense, Dr. Weinberg's \"clinical expertise\" lies in the realm of translating basic scientific discoveries into potential therapeutic targets. His \"procedures\" are not surgical or pharmacological but rather the rigorous scientific methods he employs to identify and characterize oncogenes and their roles in cancer development.\n\nHis expertise centers around the identification and characterization of oncogenes, genes that have the potential to cause cancer when mutated or overexpressed. He pioneered techniques for isolating and cloning oncogenes, allowing researchers to study their function in detail. His work on the *ras* oncogene, a key regulator of cell growth and differentiation, was particularly groundbreaking. He demonstrated that mutations in *ras* can lead to uncontrolled cell proliferation, a hallmark of cancer.\n\nFurthermore, Dr. Weinberg developed sophisticated experimental models for studying cancer in the laboratory, including the use of genetically engineered mice to mimic human cancers. These models have been invaluable for testing new therapies and for understanding the complex interplay between genes and the environment in cancer development. His work on the epithelial-mesenchymal transition (EMT), a process by which epithelial cells lose their cell-cell adhesion and gain migratory properties, has also had a profound impact on our understanding of cancer metastasis. He demonstrated that EMT is a critical step in the spread of cancer cells from the primary tumor to distant sites in the body.\n\nHis \"expertise\" also extends to the critical analysis of clinical data and the interpretation of clinical trial results. While he does not directly treat patients, he actively collaborates with clinicians to translate his research findings into clinically relevant strategies. His insights are highly sought after by pharmaceutical companies and biotechnology firms seeking to develop new cancer therapies.\n\n### 4. Academic Contributions & Research\n\nDr. Weinberg's academic contributions are monumental, fundamentally altering the course of cancer research. He is best known for his groundbreaking work on oncogenes and tumor suppressor genes, which established the genetic basis of cancer. His research has provided a framework for understanding how normal cells transform into cancerous cells, paving the way for the development of targeted therapies.\n\nHis most influential publications include his seminal papers on the identification and characterization of the *ras* oncogene, the *retinoblastoma* (Rb) tumor suppressor gene, and the role of the *p53* tumor suppressor gene in cancer. These publications have been cited thousands of times and have become cornerstones of modern cancer biology. His textbook, \"The Biology of Cancer,\" is considered the definitive resource for students and researchers in the field. It provides a comprehensive overview of the molecular and cellular mechanisms of cancer, covering topics ranging from oncogenes and tumor suppressor genes to angiogenesis and metastasis.\n\nHis research has focused on several key areas, including:\n\n*   **Oncogene Discovery:** Identifying and characterizing genes that promote cell growth and division.\n*   **Tumor Suppressor Genes:** Investigating genes that normally prevent cell growth and division, and how their inactivation contributes to cancer.\n*   **Cancer Metastasis:** Understanding the mechanisms by which cancer cells spread from the primary tumor to distant sites in the body.\n*   **Tumor Microenvironment:** Exploring the role of the surrounding tissue and immune cells in cancer development and progression.\n*   **Epithelial-Mesenchymal Transition (EMT):** Elucidating the molecular mechanisms and biological significance of EMT in cancer metastasis and drug resistance.\n\nHis research has had a profound impact on the development of targeted therapies for cancer. By identifying the specific genes and proteins that drive cancer growth, researchers have been able to develop drugs that specifically target these molecules, leading to more effective and less toxic treatments. His work on the *HER2* oncogene, for example, led to the development of trastuzumab (Herceptin), a monoclonal antibody that has revolutionized the treatment of breast cancer.\n\n### 5. Patient Impact & Community Work\n\nWhile Dr. Weinberg's contributions are primarily in the realm of basic science, their impact on patient outcomes is undeniable. His research has provided the foundation for the development of numerous targeted therapies that have significantly improved the survival rates and quality of life for cancer patients. Drugs targeting *ras*, *HER2*, *EGFR*, and other oncogenes identified through his work are now standard treatments for a variety of cancers.\n\nAlthough the specifics of his community work remain private, it is known that he is a strong advocate for increased funding for cancer research and for the development of more effective cancer treatments. He frequently speaks at scientific conferences and public forums, raising awareness of the importance of cancer research and the need for continued investment in this area. He also actively mentors young scientists, encouraging them to pursue careers in cancer research and to make their own contributions to the fight against this devastating disease. He has trained a generation of leading cancer researchers who are now making their own significant contributions to the field.\n\nHis influence extends beyond the scientific community. He has served as an advisor to numerous government agencies and private organizations, providing guidance on cancer research policy and funding priorities. His expertise is highly sought after by policymakers and healthcare professionals seeking to improve cancer prevention, diagnosis, and treatment.\n\n### 6. Legacy and Future Outlook\n\nDr. Robert A. Weinberg's legacy is secure as one of the most influential figures in modern cancer biology. His groundbreaking discoveries have transformed our understanding of cancer and have paved the way for the development of new and more effective therapies. His work has not only advanced scientific knowledge but has also had a tangible impact on the lives of millions of cancer patients worldwide.\n\nHis contributions have been recognized with numerous prestigious awards and honors, including the National Medal of Science, the Lasker Award for Basic Medical Research, and the Wolf Prize in Medicine. He is a member of the National Academy of Sciences and the Institute of Medicine, and he has served on numerous advisory boards and committees.\n\nLooking to the future, Dr. Weinberg remains actively engaged in cancer research, continuing to explore new avenues of investigation and to push the boundaries of our understanding of this complex disease. He is particularly interested in the role of the tumor microenvironment in cancer development and progression, and he is exploring new strategies for targeting the tumor microenvironment to improve cancer therapy. He also remains committed to mentoring young scientists and to fostering the next generation of cancer researchers. His ongoing work promises to further refine our understanding of cancer and to lead to even more effective treatments in the years to come. His influence will undoubtedly continue to shape the field of cancer research for decades to come, ensuring his place in the annals of medical history. He is a true pioneer, a visionary scientist, and a champion for cancer patients everywhere.\n",
  "bioGenerated": true
}